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Abstract
Here we present the synthesis, the biophysical properties, and the RNase H profile of 6’-difluorinated [4.3.0]bicyclo-DNA (6’-diF-
bc4,3-DNA). The difluorinated thymidine phosphoramidite building block was synthesized starting from an already known gem-
difluorinated tricyclic glycal. This tricyclic siloxydifluorocyclopropane was converted into the [4.3.0]bicyclic nucleoside via cyclo-
propane ring-opening through the addition of an electrophilic iodine during the nucleosidation step followed by reduction. The
gem-difluorinated bicyclic nucleoside was then converted into the corresponding phosphoramidite building block which was incor-
porated into oligonucleotides. Thermal denaturation experiments of these oligonucleotides hybridized to complementary DNA or
RNA disclosed a significant destabilization of both duplex types (ΔTm/mod = −1.6 to −5.5 °C). However, in the DNA/RNA hybrid
the amount of destabilization could be reduced by multiple insertions of the modified unit. In addition, CD spectroscopy of the
oligonucleotides hybridized to RNA showed a similar structure than the natural DNA/RNA duplex. Furthermore, since the struc-
tural investigation on the nucleoside level by X-ray crystallography and ab initio calculations pointed to a furanose conformation in
the southern region, a RNase H cleavage assay was conducted. This experiment revealed that the oligonucleotide containing five
modified units was able to elicit the RNase H-mediated cleavage of the complementary RNA strand.
Introduction
The fluorine atom is a very attractive substituent in medicinal
chemistry due to the beneficial biological effects induced by
this atom on the overall drug behaviour [1-5]. The positive
influences on the drug behaviour is not limited to small mole-
cules but is also valid for antisense oligonucleotides (AONs)
[6]. An effective way to tune the properties of antisense oligo-
nucleotides is by the insertion of the fluorine atom in the sugar
moiety of the nucleoside. In this way, the sugar pucker can be
controlled which ideally results in an increased affinity towards
complementary RNA [7]. An improved affinity for RNA as
complement can be found in DNA oligonucleotides containing
2’-deoxy-2’-fluoro-RNA (F-RNA) [8] or 2’-deoxy-2’-fluoroara-
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Figure 1: Chemical structure of selected fluorine-modified nucleic acids.
bino nucleic acid (F-ANA, Figure 1) [9]. In the former the sugar
pucker adopts a C3’-endo conformation [10] and the duplex for-
mation is entropically stabilized. The reason for the stabiliza-
tion is an increased strength of the Watson–Crick base pairing
and base stacking interactions due to the electronic effects of
the axially oriented 2’-fluorine atom [11,12]. Additionally,
FC–H···O hydrogen bonds between the 2’-fluorine and the
4’-oxygen or 5’-oxygen of the 3’-adjacent nucleotide are
thought to favourably contribute in both F-RNA and F-ANA
duplexes [13]. Furthermore, in duplexes of the F-ANA with
complementary RNA, internucleosidic C–H···F–C pseudohy-
drogen bonds are proposed at pyrimidine-purine steps to addi-
tionally stabilize the structure [14,15]. The β-orientation of the
fluorine substituent in F-ANA leads to a gauche interaction be-
tween O4’–C1’–C2’–F2’ favouring the C2’-endo/O4’-endo
conformations of the sugar in solution [16,17]. These DNA-like
sugar conformations cause that F–ANA is among the few modi-
fications which can trigger the cleavage of the RNA strand of
an AON/RNA hybrid structure by the endonuclease RNase H
[9,18]. Both, the F–ANA and the F–RNA, are appealing modifi-
cations for several oligonucleotide-based silencing applications
[8,19-25].
Also evaluated on their antisense properties were the 3’-fluori-
nated hexitol nucleic acids FHNA and Ara-FHNA (Figure 1)
with the fluorine in axial or equatorial orientation, respectively.
Both modifications preferentially adopt a chair conformation
with the nucleobase in axial orientation which mimics the C3’-
endo conformation of the furanose ring. Thermal denaturation
experiments with complementary RNA displayed a duplex
stabilization for FHNA and a duplex destabilization for Ara-
FHNA. The reason for the stabilization of the former was
accounted to a combination of the increased rigidity of the six-
membered ring and the positioning of the axial oriented fluo-
rine atom pointing into the minor groove. Conversely, in the
Ara-FHNA, repulsive electrostatic interactions between the
fluorine atom and the 4’-oxygen of the 3’-adjected nucleotide
resulted in a partial unstacking of the nucleobases and a destabi-
lizing effect upon duplex formation [26]. Also other fluorinated
nucleic acids such as 2’-fluorocyclohexenyl nucleic acid
(F-CeNA, Figure 1) [27] and other modifications [28-31] have
been analyzed on their antisense properties.
In our own work we already investigated the effect of the fluo-
rine substituent at various positions of the [3.3.0]bicyclo-DNA
(bc-DNA) and tricyclo-DNA (tc-DNA) scaffold. All these mod-
ifications unveiled an either identical or slightly increased
affinity versus complementary RNA compared to their non-
fluorinated compounds [32-35]. Interestingly, the 2’F-tc-ANA
(Figure 1) exhibited in a sequence- and composition-dependent
manner the ability to induce the RNase H cleavage of the com-
plementary RNA strand [35]. In continuation of our work we
became interested in the fluorination of [4.3.0]bicyclo-DNA
[36]. Consequently, the 6’-position of the [4.3.0]bicyclo-DNA
was substituted with a difluoromethylene group, and the struc-
tural effect of this functional unit was explored. Herein we
report on the synthesis and properties of the 6’-diF-bc4,3-thymi-
dine analog (Figure 1), and the biophysical properties of oligo-
nucleotides containing this modification. Moreover, we investi-
gated the substrate recognition of the 6’-diF-bc4,3-T analog by
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Scheme 1: Synthesis of the bicyclic nucleoside 6. Reagents and conditions: a) BSA, thymine, NIS, DCM, 0 °C to rt, 26 h; b) Bu3SnH, AIBN, toluene,
90 °C, 30 min, 34% (5α/β), 48% (6) over two steps.
Table 1: Evaluation of the reaction mechanism for the production of bicyclic nucleoside 6.
Entry Starting material Bu3SnH (equiv) AIBN (equiv) Yield 5α/β [%] Yield 6 [%]
1 1a 1.5 0.5 70b 21b
2 2α/β 1.5 0.1 82 –
3 5α/β 2.5 0.1 93 –
4 3/4 3.1 0.1 – 64
5 1c 3.5 0.1 34b 48b
aFirst treated with: thymine (3 equiv), BSA (4.5 equiv), NIS (1.5 equiv), DCM, 0 °C to rt, 4.5 h. bYield over two steps. cFirst reacted with: thymine
(3 equiv), BSA (4.5 equiv), NIS (2 equiv), DCM, 0 °C to rt, 26 h.
RNase H. In addition, the RNase H experiment was also per-
formed with the previously report 6’F-bc4,3-DNA (Figure 1)
[37].
Results and Discussion
Synthesis of the phosphoramidite building
block
In the literature there exist several procedures to construct an
α,α-difluoroketone from a corresponding siloxydifluorocyclo-
propane [38-40]. However, based on previous observations in
the nucleoside synthesis of the 6’F-bc4,3-T [37] we thought to
construct the 6’-diF-bc4,3 building block in utilizing this meth-
odology. Along this synthesis, the glycal 1 was treated with
N-iodosuccinimide (NIS) in the presence of persilylated
thymine to produce the iodine intermediates 2α/β (Scheme 1,
Table 1, entry 1). These instable intermediates were then
directly reduced with tributyltin hydride (Bu3SnH) to yield the
tricyclic nucleosides 5α/β as main compounds. However, we
observed the occurrence of the gem-difluorinated bicyclic
nucleoside 6 as the main side product. Since nucleoside 6
possessed the desired stereochemistry at the 1’- and the 5’-posi-
tions, we investigated the mechanism of its formation in more
detail to be able to increase its yield. To determine in which of
the two steps the formation of the nucleoside 6 took place, they
had to be analyzed separately. Therefore, a sample of the iodi-
nated nucleosides 2α/β was purified and subjected to the reduc-
tion reaction, where nucleosides 5α/β were formed as single
products (Table 1, entry 2). Also, the conversion of the nucleo-
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Scheme 2: Synthesis of the thymidine phosphoramidite building block 9. Reagents and conditions: a) HF-pyridine, DCM/pyridine 5:1, 0 °C to rt, 2.5 h,
64%; b) DMTr-OTf, DCM/pyridine 1:2, rt, 22 h, 56%; c) CEP-Cl, DIPEA, THF, rt, 3 h, 73%.
sides 5α/β into the bicyclic derivative 6 could be ruled out
(Table 1, entry 3). Consequently, the bicyclic derivative 6 was
thought to have its origin in the NIS-mediated nucleosidation
step. In analyzing the crude reaction product in more detail,
apart from the iodinated nucleosides 2α/β, the presence of an
inseparable mixture of two diiodo-substituted products was
unveiled. The major product was the bicyclic gem-diol 4 and
the minor one the corresponding ketone 3. We hypothesize that
the α,α-difluoroketone 3 was formed through a cyclopropane
ring-opening followed by the addition of the electrophilic iodine
in accordance to what was reported by the Dilman group [40].
The α,α-difluoroketone 3 rapidly underwent hydration in a re-
versible way to form the gem-diol 4. The stereochemistry of
compound 4 could be assessed indicating the selective forma-
tion of the β-nucleoside with the addition of the iodine at the
7’-position from the exo-face. Even though we were not able to
verify the relative configuration of ketone 3, we expect the
same stereochemistry at the 1’-, 2’- and 7’-positions as in
nucleoside 4. The confirmation that the diiodo-substituted de-
rivatives 3/4 were the precursors of nucleoside 6 came from an
experiment in which 3/4 was treated with Bu3SnH resulting in
nucleoside 6 as the only observed product (Table 1, entry 4).
The S-configuration at the 5’-position of nucleoside 6 could be
explained by a Felkin–Ahn transition state with the hydrogen
radical attacking from the less hindered exo-face [41,42]. Opti-
misation of the nucleosidation conditions to an increased
amount of NIS (2 equiv) and prolongation of the reaction time
in combination with the adjustment of the Bu3SnH amount to
3 equivalents led to higher yields of the bicyclic nucleoside 6
(Table 1, entry 5). An additional proof for the reaction mecha-
nism came from the outcome of the reaction where a tricyclic
sugar was first treated with NIS and then with Bu3SnH result-
ing as expected in a gem-difluorinated bicyclic sugar (Scheme
S1, Supporting Information File 1). This reaction also ruled out
the involvement of the nucleobase or the iodine at the 2’-posi-
tion in the reaction mechanism.
Having attained nucleoside 6, the synthesis towards the build-
ing block for DNA-synthesis continued by subsequent desilyl-
ation of this derivative producing intermediate 7 (Scheme 2). Figure 2: X-ray structure of nucleoside 6a (left) and 6b (right).
DMTr-protection of compound 7 at the 5’-oxygen with in situ
prepared DMTr-OTf [43,44] followed by phosphitylation at the
3’-oxygen afforded the phosphoramidite 9.
X-ray structure and molecular modeling of
the 6’-diF-bc4,3 nucleoside
To verify the relative configuration of nucleoside 6, crystals of
this compound were subjected to X-ray diffraction analysis. The
asymmetric unit of a single crystal of nucleoside 6 contained
two independent molecules which differed only in the confor-
mation around the C3’–O3’ bond (Figure 2, Table 2, and Tables
S1–S3, Supporting Information File 1) [45]. The sugar pucker
of both molecules expressed the C2’-endo conformation with
the pseudorotation phase angle P adopting values of 175° (6a)
and 181° (6b), respectively. The maximum puckering ampli-
tude νmax was 43° (6a) and 40° (6b). Furthermore, the nucleo-
base displayed an anti orientation. The carbocyclic ring adopted
a chair conformation. As a consequence, the angle γ was
aligned in the synclincal range and the 5’-hydroxy group in an
axial arrangement. Additionally, the distance between the
5’-oxygen and the equatorial fluorine atom Fa of 2.80 Å (6a)
and 2.73 Å (6b) correlated with the sum of their van der Waals
radii (Table S1, Supporting Information File 1). Interestingly,
the two fluorine atoms had an effect on the C5’–C6’ and the
C6’–C7’ bond length which were shorter than other C–C bonds
Beilstein J. Org. Chem. 2019, 15, 79–88.
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Table 2: Selected parameters from the crystal structure of nucleoside 6 and the standard bc4,3-T.
Nucleoside P [°] νmax [°] γ [°] δ [°] χ [°] C5’–C6’–C7’ [°] X–C6’–Xa [°]
6a 175 43 74 158 −108 114 105
6b 181 40 72 164 −82 114 105
bc4,3-T (a)b 174 42 70 162 −105 111 108
bc4,3-T (b)b 166 43 71 154 −120 110 108
a6a/b: X = F, bc4,3-T: X = H. bThe structures a and b were two different molecules in the same unit. Data taken from ref [36].
Figure 3: a) Potential energy profile versus pseudorotation phase angle of nucleoside 7 and b) its minimal energy conformer.
in the cyclohexyl ring (Table S2, Supporting Information
File 1). Furthermore, the difluoromethylene unit affected the
C5’–C6’–C7’ angle and the F–C6’–F angle. The former was
widened and the latter shortened compared to the structure of
the non-fluorinated bc4,3-T (Table 2 and Table S3, Supporting
Information File 1). This phenomenon was also observed for
other difluoromethylene containing compounds [46]. Apart
from that, the observed parameters of the 6’-diF-bc4,3-T were
very similar to the ones of the bc4,3-T, indicating that at least on
the nucleoside level the fluorine atoms seemed to have a minor
effect on the overall structure.
To further study the preferred sugar pucker of the 6’-diF-bc4,3-
T nucleoside, a potential energy profile versus pseudorotation
phase angle of nucleoside 7 was calculated using quantum me-
chanical methods. For the calculations we used the Gaussian 09
software package [47] at the second order Møller–Plesset
(MP2) level of theory, the 6-311G* basis set, and the same
methodology as for the 6’F-bc4,3- T [37]. The obtained energy
profile of nucleoside 7 (Figure 3a) surprisingly showed only
one single low energy region in the Southern area of the
pseudorotational cycle. The minimal energy conformer of
nucleoside 7 adopted a C2’-endo furanose conformation
(P = 160°) and a twist-boat orientation of the carbocyclic unit
(Figure 3b). Hence, the angle γ took up a synclincal arrange-
ment and the 5’-hydroxy group a pseudoaxial orientation.
Again, the spacing between the 5’-oxygen and the equatorial
aligned fluorine atom Fa of 2.61 Å corresponded to the sum of
their van der Waals radii. Interestingly, this distance was shorter
in the minimal conformer of nucleoside 7 than in the obtained
crystal structure of derivative 6 (Table S1, Supporting Informa-
tion File 1). The reason for that can be attributed to the
different conformations of the six-membered rings in these
two structures. Apart from that, the two structures were very
similar.
Synthesis of the modified oligonucleotides
and their thermal melting profiles
The phosphoramidite building block 9 was incorporated into
oligonucleotides and duplexed to complementary DNA and
RNA to determine the effect of the 6’-diF-bc4,3-T modification
on the helical structure and duplex thermostability. The se-
quences chosen for the investigation were the same as previ-
ously used for the 6’F-bc4,3-DNA (ON1: 5’-d(GGA TGT TCt
CGA)-3’, ON2: 5’-d(GGA tGT TCT CGA)-3’, ON3:
5’-d(GGA TGt tCT CGA)-3’, ON4: 5’-d(GCA ttt ttA CCG)-3’)
Beilstein J. Org. Chem. 2019, 15, 79–88.
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Table 3: Tm and ΔTm/mod data from UV-melting curves (260 nm) of ONs containing 6’-diF-bc4,3-T, 6’F-bc4,3-T, or bc4,3-T residues in the DNA back-
bone hybridized to complementary DNA and RNA.
Entry Sequence (5’ → 3’)a Tm [°C] vs DNA (ΔTm/mod [°C]) Tm [°C] vs RNA (ΔTm/mod [°C])
X = 6’-diF-bc4,3-T 6’F-bc4,3-T bc4,3-Tb 6’-diF-bc4,3-T 6’F-bc4,3-T bc4,3-Tb
1 d(GGA TGT TCX CGA) 43.5 (−5.2) 46.0 (−2.7) 47.3 (−0.2) 44.5 (−5.5) 46.0 (−4.0) 48.9 (−0.8)
2 d(GGA XGT TCT CGA) 47.1 (−1.6) 47.2 (−1.5) 46.1 (−1.4) 47.9 (−2.1) 47.6 (−2.4) 47.4 (−2.3)
3 d(GGA TGX XCT CGA) 40.3 (−4.2) 41.3 (−3.7) 47.0 (−0.3) 43.3 (−3.4) 42.0 (−4.0) 51.0 (+0.7)
4 d(GCA XXX XXA CCG) 20.2 (−5.4) 30.3 (−3.4) – 22.0 (−4.5) 22.4 (−4.4) –
aTotal strand conc. 2 μM in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0. Tm values of unmodified duplexes: DNA1/DNA = 48.7 °C, DNA1/RNA = 50.0 °C,
DNA2/DNA = 47.4 °C, DNA2/RNA = 44.4 °C; DNA1 = 5’-d(GGA TGT TCT CGA)-3’, DNA2 = 5’-d(GCA TTT TTA CCG)-3’. bData taken from ref [36].
[37]. UV-melting experiments of the modified duplexes were
recorded to assess the affinity of the 6’-diF-bc4,3-T modified
oligonucleotides towards complementary DNA and RNA
(Table 3). A single insertion of a 6’-diF-bc4,3-T into DNA
strands led to a remarkable duplex destabilization versus both
complements (ΔTm/mod = −1.6 to −5.5 °C) in a sequence spe-
cific manner but with a slight lesser degree of destabilization
towards complementary DNA. However, the degree of destabi-
lization was further minimized with two consecutive insertions
of the 6’-diF-bc4,3-T (ΔTm/mod = −4.2 °C and −3.4 °C for com-
plementary DNA and RNA, respectively), whereas five consec-
utive 6’-diF-bc4,3-T units depressed the duplex stability of both
structures again (ΔTm/mod = −5.4 °C and −4.5 °C for comple-
mentary DNA and RNA, respectively). Interestingly, the DNA/
RNA hybrid structure better accommodated multiple 6’-diF-
bc4,3-Ts than a single insertion. Additionally, the hybrid struc-
ture also better tolerated multiple 6’-diF-bc4,3-T units than the
DNA/DNA duplex. The reason for the destabilizing nature of
the 6’-diF-bc4,3-T versus both complements might be found in
repulsive electrostatic interactions between the fluorine atoms
and the 5’-oxygen. In the case of multiple insertions it might be
possible that these interactions might be reduced or maybe
compensated by other more favourable effects. The fact, that
the two fluorine atoms of the 6’-diF-bc4,3-T have a negative in-
fluence on the duplex stability was reflected in the higher Tm
values of ONs containing the non-fluorinated bc4,3-T unit
paired to DNA or RNA (Table 3). However, the Tm difference
between duplexes containing the 6’-diF-bc4,3-T or the 6’F-
bc4,3-T modifications are harder to be interpreted and may
reflect different structural preferences between the cyclohexyl
to the cylcohexenyl ring. But in general, the duplex instability
in the DNA/DNA structures was more pronounced in the
6’-diF-bc4,3-T series, whereas to complementary RNA the
modified oligonucleotides exhibited a similar degree of destabi-
lization in both series.
An interesting behaviour was observed for the sequence of
Table 3, entry 2. There, the ON of the three bc4,3-T analogs not
only showed almost identical Tm values when paired to DNA
but also to complementary RNA. This means that at least in this
sequence context the fluorine atoms had no impact on the
duplex stability and the destabilization arose only from the
bicyclic scaffold. Whether this finding is a general behaviour or
a consequence of the A–X–G nearest neighbour interactions
cannot be stated at present.
The base pairing selectivity of the 6’-diF-bc4,3-T was evaluated
by UV-melting experiment of ON1 by inserting one of the three
possible mismatches (G, C, or T) opposite the modified unit in
the otherwise complementary DNA strand (Table 4). As antici-
pated, the mispairing led to a strong decrease of the melting
temperature (Tm = −8.5 to −13.8 °C) with the GT-Wobble
mispair exhibiting the least destabilizing effect. Comparing
these values to the ones of the natural system revealed that the
modification discriminated the mismatches more efficiently.
Consequently, this finding indicated a higher tendency for
mismatch discrimination of the 6’-diF-bc4,3-T over dT.
To gain more information about the helical structure of ON1–4
hybridized to complementary DNA or RNA, CD spectra of
these duplexes were recorded (Figure 4). The duplexes of the
four ONs paired to DNA still showed the overall shape of a
B-type helix [48], although some duplexes exhibited slight dis-
tortions. Modest changes of the ellipticity amplitude maxima in
the ON3/DNA duplex existed compared to the natural system.
Also, some deviation from the natural structure displayed the
ON4/DNA duplex. There, the band at 245 nm was depressed
and the two positive ellipticities (≈220 nm and ≈280 nm)
expressed increased intensities. Besides this, the ellipticity at
280 nm was blue-shifted (≈6 nm). All four modified DNA/RNA
hybrids exhibited the characteristic shape of an intermediate
A/B-type helix [48]. Again, some slight deviations from the
natural system could be observed for the 6’-diF-bc4,3-T contain-
ing duplexes. The most distinct deviations occurred in the case
of the ON4/RNA duplex. There the band at 225 nm was blue-
shifted (≈5 nm) and the one at 245 slight red-shifted (≈2 nm)
Beilstein J. Org. Chem. 2019, 15, 79–88.
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Table 4: Tm data [°C] from UV-melting curves (260 nm) of ON1 in duplex with complementary mismatched DNA.
Entry Sequencea X = A X = T X = G X = C
DNA1 5’-d(GGA TGT TCT CGA)-3’ 48.7 39.0 40.2 37.3
DNA 5’-d(TCG XGA ACA TCC)-3’ (−9.7) (−8.5) (−11.4)
ON1 5’-d(GGA TGT TCt CGA)-3’ 43.5 29.7 35.0 30.7
DNA 5’-d(TCG XGA ACA TCC)-3’ (−13.8) (−8.5) (−12.8)
aLowercase letters: modified nucleotide, capital letters: natural DNA. Total strand conc. 2 μM in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0.
Figure 4: CD spectra of ON1–4 with complementary a) DNA, and b) RNA. Total strand conc. 2 μM in 10 mM NaH2PO4, 150 mM NaCl, pH 7.0.
and both intensities were changed, too. Furthermore, the inten-
sity of the 210 nm peak was reduced.
RNase H cleavage assay
The most important requirement for an antisense oligonucleo-
tide to induce RNase H activity lies in its DNA-like sugar con-
formations [49]. This is generally fulfilled by the 6’-diF-bc4,3-
DNA as well as the 6’F-bc4,3-DNA. Furthermore, duplexes of a
6’F-bc4,3-modified strand paired to RNA unveiled in the MD
simulations a flexible minor groove distance [37]. This flexi-
bility is thought to play a crucial role for the fitting of the
duplex into the DNA-binding channel and the phosphate-
binding pocket of the enzyme. Furthermore, the phosphate-
binding pocket requires a large distortion of the backbone angle
α in order that the phosphate group of the AON can be posi-
tioned in it [50,51]. The 6’F-bc4,3-DNA containing strand also
complied with this requirement according to the MD simula-
tions [37]. Therefore, we examined the ability of the 6’F-bc4,3-
DNA and the 6’-diF-bc4,3-DNA to induce the RNase H-medi-
ated cleavage of the complementary RNA strand by utilizing
the sequence of ON4 (5’-d(GCA ttt ttA CCG)-3’) and a
chimeric sense strand. The sense strand consisted of five
consecutive ribo-A units placed opposite the modified part and
2’-O-methyl RNA flanks. The same construct was previously
applied for the evaluation of 2’F-tc-ANA [35] and a similar one
for CeNA [52]. For the assay E. coli RNase H was used due to
its commercial availability and its similarity to the human en-
zyme [22].
The cleavage pattern of the RNase H is presented in Figure 5. In
the DNA/RNA positive control, the RNA strand was complete-
ly cleaved as expected (lane 1). In the negative controls C1 (no
antisense strand) and C2 (no enzyme) no degradation of RNA
could be observed (lanes 9 and 10). Acceptable substrates for
the RNase H were duplexes containing both the 6’F-bc4,3-DNA
(lanes 3–5) and the 6’-diF-bc4,3-DNA (lanes 6–8). The latter
was able to induce a more efficient cleavage of the complemen-
tary RNA strand than the former. Nevertheless, both modifica-
tions recruited the RNase H to a lower extent than natural DNA.
The 2’F-tc-ANA modification that has previously been shown
to induce RNase H cleavage in a different sequence context was
only modestly active (lane 2). Overall, the two new fluorinated
bc4,3-analogs are among the few modifications which are able
to activate RNase H to some extent. These promising results in-
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dicate that the 6’-diF-bc4,3-DNA and the 6’F-bc4,3-DNA may
find application in therapeutic gapmer oligonucleotides.
Figure 5: Hydrolysis products of the RNase H activation assay. The
DNA served as positive control, whereas C1 (no antisense strand) and
C2 (no enzyme) were negative controls.
Conclusion
In this report, we presented the successful synthesis of the
6’-diF-bc4,3-T building block where the gem-difluorinated
bicyclic unit was formed starting from a previously described
tricyclic siloxydifluorocyclopropane. The reaction of this
tricyclic sugar under NIS-mediated nucleosidation produced
two diiodo-substituted intermediates which were reduced by
Bu3SnH yielding the β-nucleoside 6 as the only diastereoiso-
mer. The crystal structure of nucleoside 6 exhibited the C2’-
endo conformation of the furanose ring and the gauche orienta-
tion of the torsions angle γ. Conversion of this nucleoside into
the corresponding phosphoramidite building block and its incor-
poration into oligonucleotides was then successfully achieved.
Thermal melting experiment of the modified oligonucleotides
paired to complementary DNA or RNA revealed a prominent
duplex destabilization for both duplex types (ΔTm/mod = −1.6
to −5.5 °C). A lesser degree of destabilization was observed for
oligonucleotides containing several consecutive modifications
hybridized to complementary RNA. The reason for the destabi-
lization might be accounted to repulsive electrostatic interac-
tions between the equatorial fluorine atom and the 5’-oxygen.
CD spectroscopy of the duplexes disclosed that the helical
structure of the modified oligonucleotides paired to comple-
mentary DNA was still of a B-type, whereas an intermediate
A/B-type helix was observed for RNA as complement. Further-
more, the RNase H assay of the oligonucleotide containing
either five consecutive 6’-diF-bc4,3-Ts or 6’F-bc4,3-Ts paired to
complementary RNA revealed that both modifications were
able to recruit this enzyme. In both cases the RNase H cleaved
the complementary RNA strand less efficiently as compared to
the natural DNA/RNA duplex. This is a promising finding
which points to a possible application for both modifications in
therapeutic gapmer oligonucleotides.
Supporting Information
Supporting Information File 1
Additional information, experimental procedures, NMR
spectra, and crystallographic data.
[https://www.beilstein-journals.org/bjoc/content/
supplementary/1860-5397-15-9-S1.pdf]
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